Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients
Alizamin Sadigov (Baku, Azerbaijan), Alizamin Sadigov, Konul Abasaliyeva, Sakhvatdin Akhundov, Gunel Sadigova
|   |
Alpha1-antytripsin deficiency in portuguese COPD patients
Ana Filipa Cruz e Costa (Taveiro, Portugal), Ana Filipa Cruz e Costa, Cidália Rodrigues, Pedro Ulisses Brito
| |
Heterogeneity inside group D COPD patients: About 827 cases
Ahmed Ben Saad (5000 Monastir, Tunisia), Ahmed Ben Saad, Saoussen Cheikh Mhammed, Hadhami Mribah, Nesrine Fahem, Samah Joobeur, Naceur Rouatbi, Ali El Kamel
| |
CAT predicts mortality in COPD patients who require LTOT
Nikolay Kyuchukov (Belene, Bulgaria), Nikolay Kyuchukov, Nikolay Yanev, Iliya Krachunov, Zlatina Ivanova, Preslava Kyuchukova, Petkana Hristova, Plamen Pavlov, Pavlina Glogovska, Tsanya Popova, Yavor Ivanov
| |
Plasma surfactant protein-D (SPD) concentration and severity of airflow limitation in COPD patients (pts)
Kateryna Gashynova (Dniepropetrovsk, Ukraine), Kateryna Gashynova, Tetyana Pertseva
| |
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
Andrea Vukic Dugac (Zagreb, Croatia), Andrea Vukic Dugac, Alen Ruzic, Ana Hecimovic, Mateja Jankovic-Makek, Gordana Pavlisa, Hrvoje Puretic, Gzim Redjepi, Sanja Popovic-Grle, Miroslav Samarzija, Marko Jakopovic
| |
Blood pressure variability during the 6-minute walk test in patients with chronic obstructive pulmonary disease
Arnoldus van Gestel (Winterthur, Switzerland), Arnoldus van Gestel, Andrja Gajic, Florent Baty, Martin Brutsche
| |
The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils
Paola Rogliani (Rome, Italy), Paola Rogliani, Ermanno Puxeddu, Chiara Ciaprini, Gabriella Pezzuto, Luigino Calzetta, Mario Cazzola
| |
Do inhaled corticosteroids reduce the frequent exacerbator phenotype in COPD - A little help by a multicenter survey
Dieter Klopf (Nürnberg, Germany), Dieter Klopf, Johannes Rumpf, Peter Maier-Stocker, Kai Thomas, Christoph Koehl, Claudia Sommer, Peter Berg
| |
GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation
Evgeni Mekov (Sofia, Bulgaria), Evgeni Mekov, Yanina Slavova, Adelina Tsakova, Marianka Genova, Dimitar Kostadinov, Delcho Minchev, Dora Marinova, Mihail Boyanov
| |
Resting heart rate and exacerbations in COPD patients
Ahmad Izuanuddin Ismail (Selangor, Malaysia), Ahmad Izuanuddin Ismail, Aisya Natasya Musa, Mohd Arif Mohd Zim, Mohd Ariff Fadzil, Norhaya Mohd Razali, Razul Md Nazri Md Kassim, Tengku Saifudin Tengku Ismail
| |
Quality of life at discharge from hospital following acute exacerbation of COPD is much worse even if length of stay is short
Lalita Fernandes (Panaji, Goa, India), Lalita Fernandes, Rohit Vadala, Nandani Gulati, Anika Parrikar, Anthony Mesquita
| |
Airway resistance correlates with the frequency of exacerbation in patient with COPD
Hitomi Furukawa (Tokyo, Japan), Hitomi Furukawa, Yasunari Kishino, Yasunori Murata, Shin Ohta, Tetsuya Honma, Sojiro Kusumoto, Mayumi Yamamoto, Shintaro Suzuki, Akihiko Tanaka, Takuya Yokoe, Tsukasa Ohnishi, Hironori Sagara
| |
Alpha-1-antitrypsin deficiency in Kazakh subjects with COPD
Ardak Zhumagaliyeva (Semey, Kazakhstan), Ardak Zhumagaliyeva, Marina Gorrini, Claus Vogelmeier, Angelo Corsico, Ludmila Karazhanova, Timm Greulich, Annalisa DeSilvestri, Victor Kotke, Valentina Barzon, Michele Zorzetto, Ilaria Ferrarotti
| |
Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients
Renáta Marietta Böcskei (Budapest, Hungary), Renáta Marietta Böcskei, Lilla Tamási, Béla Benczúr, András Bikov, György Losonczy, Anikó Bohács
| |
The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Louise Goodall (Sydney, Australia), Louise Goodall, Belinda Cochrane, Soo Wei Foo, Phong Nguyen
| |
Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease?
Nagihan Durmus Kocak (Istanbul, Turkey), Nagihan Durmus Kocak, Gulsah Sasak, Ulku Aka Akturk, Metin Akgun, Sibel Boga, Aysun Sengul, Sinem Gungor, Sibel Arinc
| |
Relation of high resolution computed tomography findings with functional parameters in COPD
Gülden Bilgin (Ankara, Turkey), Gülden Bilgin, Pinar Nercis Kosar, Enver Necip Köseoglu
| |
The association between morning symptoms and physical activity in chronic obstructive pulmonary disease: A systematic review
Amanda van Buul (Leiden, Netherlands), Amanda van Buul, Marise Kasteleyn, Niels Chavannes, Christian Taube
| |
LATE-BREAKING ABSTRACT: Five items from the CAT questionnaire identify smokers with preserved lung function at higher risk for poor respiratory outcomes: An analysis of the SPIROMICS cohort
Carlos Martinez (Ann Arbor, United States of America), Carlos Martinez, Susan Murray, Miguel Quibrera, Prescott Woodruff, Graham Barr, Christopher Cooper, Russell Bowler, Eugene Bleecker, Alejandro Comellas, Stephanie Christenson, David Couper, Jeffrey Curtis, Natalia Gouskova, Gerald Criner, Nadia Hansel, Eric Hoffman, Mark Dransfield, Jerry Krishnan, Nancy Leidy, Richard Kanner, Eric Kleerup, Stephen Lazarus, Fernando Martinez, Wanda O’Neal, Robert Paine, Stephen Rennard, Donald Tashkin, Paul Jones, MeiLan Han
| |